Aldosterone-renin ratio and plasma renin activity as biomarkers for treatment response in resistant hypertension
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- HYPERTENSION RESEARCH49(10) · pp.2892 · 2026
- 피인용
- Web of Science 0Scopus 0
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2024 4.6
- ISSN
- 0916-9636
저자
- Chun, Kyeong-Hyeon제1저자Yonsei Univ Coll Med, Gangnam Severance Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea
- Lee, Chan JooYonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea
- Shin, Dong-HoSeverance Hosp, Dept Internal Med, Div Gen Internal Med, Seoul, South Korea
- Jeong, Jin-OkChungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Coll Med, Daejeon, South Korea
- Kim, Ju HanChonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea
- Ryu, JiWungHallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea
- Lee, Hae-YoungSeoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
- Choi, SeonghoonHallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea
- Lee, Eun MiDongguk Univ, Ilsan Hosp, Cardiovasc Ctr, Goyang, South Korea
- 최정현Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, Busan, South Korea
- Kim, Kwang-IlSeoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea
- Shin, JinhoHanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea
- Pyun, Wook BumEwha Womans Univ, Coll Med,Seoul Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea
- Kim, Dae-HeeUniv Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea
- Williams, BryanUCL, Inst Cardiovasc Sci, London, England
- Ihm, Sang-Hyun교신저자Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med,Div Cardiol, Dept Internal Med, Seoul, South Korea
- Park, Sungha교신저자Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea
초록
A recent randomised trial demonstrated the non-inferiority of amiloride versus spironolactone in resistant hypertension, with exploratory analyses suggesting heterogeneity in treatment response based on baseline aldosterone-renin ratio (ARR). We evaluated associations between baseline renin-aldosterone status and blood pressure-lowering responses to each agent. This post hoc subgroup analysis used data from the abovementioned trial. Among 114 patients, 113 had available ARR data and were included and stratified by median ARR into two groups. Subgroup analyses were also performed according to baseline plasma renin activity (PRA) levels. The primary endpoint was the change in home systolic blood pressure (SBP) from baseline to 12 weeks. Patients with higher ARR were older and had higher baseline SBP than those with lower ARR. Multivariate regression analysis showed that female sex, higher nighttime SBP, higher ARR, and lower PRA were associated with a greater reduction in home SBP in response to treatment. In treatment-specific analyses, the home SBP-lowering response to spironolactone was pronounced in patients with higher ARR (−18.8 ± 11.6 vs −9.8 ± 8.4 mmHg, vs. lower ARR) and lower PRA (−19.1 ± 11.8 vs. −10.1 ± 8.4 mmHg, vs. higher PRA), yielding significant ARR-by-treatment (p = 0.046) and PRA-by-treatment (p = 0.027) interactions. In contrast, the home SBP-lowering response to amiloride was not significantly different according to baseline ARR or PRA. These exploratory findings suggest that renin–aldosterone profiling may help identify biological heterogeneity in treatment and warrant prospective evaluation as a candidate tool for treatment selection in resistant hypertension. (Figure presented.)
키워드
Aldosterone-renin ratioAmilorideHypertensionMorning hypertensionResistant hypertensionSpironolactone
식별자
- Scopus EID
- 2-s2.0-105047730546
- WoS UID
- 001853018900001



로그인
연구물 목록으로